INSIGHTS ON DRUG DEVELOPMENT
-
![doctor holding vial of medicine-GettyImages-1287223643]( "A Patented Process For Intermediates Useful For Upadacitinib")
A Patented Process For Intermediates Useful For UpadacitinibDiscover how innovative and safer synthetic strategies can streamline the manufacture of Upadacitinib while addressing the complexity and safety challenges inherent in its key intermediates.
-
![getty-2228810056-smart-playbook-digital-book]( "The Work That Never Shows Up In Your QA Plan")
The Work That Never Shows Up In Your QA PlanManual audit prep consumes valuable quality capacity. Transitioning to continuous readiness automates evidence generation and scales compliance efficiently.
-
![GettyImages-1302287478-powder-excipient-petri-dish]( "Transformative Innovation: Advancing Drug Development Using In Silico Modeling")
Transformative Innovation: Advancing Drug Development Using In Silico ModelingExplore how predictive modeling and in silico strategies can turn complex data into actionable insights that accelerate drug development and reduce risk across the development lifecycle.
-
![Building A Science- And Risk-Based Bio-Decontamination Strategy]( "Building A Science- And Risk-Based Bio-Decontamination Strategy")
Building A Science- And Risk-Based Bio-Decontamination StrategyAnnex 1 has made bio-decontamination central to sterility assurance, with isolator and barrier cycles now expected to be designed, justified, and reviewed across their lifecycle.
-
Navigating Shifts In Supply Chain And Manufacturing9/23/2026
As development demands grow, success depends on flexibility and resilience. Learn how manufacturers are adapting to meet new challenges.
-
Improving Bioavailability Through Predictive Modeling Of Solubility Enhancement Strategies7/15/2026
In silico modeling cut through formulation guesswork for a compound with 0.015 mg/mL solubility, delivering an 8× Cmax and 5× AUC improvement and Phase I progression.
-
Ask Us Anything: Miles Blackburn On Advances In Flow And Radical Chemistry7/23/2026
Miles Blackburn, Associate Director of Chemistry at Snapdragon Chemistry, on why the biggest payoff of flow and radical chemistry is speed — processes that scale fast enough to get intermediates and APIs delivered on a clinical timeline.
-
Streamlining Drug Development: From Developability Assessment To High-Concentration Formulation Development6/19/2025
Explore a strategic approach to accelerating biologics formulation by gaining early insight into molecular properties and optimizing high-concentration conditions with minimal protein input.
-
Navigating Complexity: Tailored Analytical & Preclinical Services2/26/2026
Tailored analytical and preclinical strategies identify risk early, integrate data-driven insight, and streamline formulation planning to accelerate timelines and position complex molecules for scalable, successful development.
DRUG DEVELOPMENT SOLUTIONS
-
![leica-microsystems-s-apo-hero]( "Stereo Microscope For High Magnification Power And Reduced Inspection Time")
S APO Greenough Stereo Microscope
Save up to 20% inspection and rework time*
Continuously improving production, keeping defect rates low, and fulfilling customer requests in order to stay competitive can be very challenging. Leica has developed the S9 stereo microscope series to help you cope with these challenges. With this generation of Greenough stereo microscopes operators will be able to reveal details faster as they spend less time having to adjust the microscope.
*compared to the standard industrial stereo microscope S6 from Leica
-
![GettyImages-1327977866-cell-culture-sample-laboratory]( "Powering Production Of Viral Vector-Based Therapies")
Gene therapies hold immense potential to provide long-lasting treatments for a wide range of diseases. At Cytiva, we offer GMP-compliant, end-to-end manufacturing solutions designed to support the development and commercialization of advanced medicines across multiple modalities – including AAV, adenovirus (AV), lentivirus (LV), plasmid DNA (pDNA) and exosomes. Our dependable suite of technologies and expertise ensures scalability, quality, and regulatory confidence at every stage of your journey.
-
![iStock-1172202165-plan]( "Develop. De-risk. Deliver.")
Our solutions are tailored to guide and optimize your efforts, so you can be confident in your development strategy and execution plan. While we have a wide range of offerings ready and available, we are driven by one goal—to help you successfully realize yours.
-
![data analytics, financial investment-GettyImages-2154830395]( "Predict Smarter. De-Risk Earlier.")
Developability liabilities that surface late leave little room to re-engineer. Standardized assay data and complete datasets support earlier risk detection, more reliable AI predictions, and more.
-
![iStock-186109117-equipment-worker-lab]( "Continuous Flow")
Our team of experts can assess processes for suitable application of continuous flow culminating in the custom development of processes incorporating proof-of-concept to cGMP manufacturing and commercialization.
